Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Director/PDMR Shareholding

28 Aug 2015 15:10

RNS Number : 5019X
Apax Global Alpha Limited
28 August 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES OR TO "US PERSONS" (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) OR INTO OR WITHIN AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN. RECIPIENTS OF THIS ANNOUNCEMENT IN JURISDICTIONS OUTSIDE THE UK SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE LEGAL REQUIREMENTS IN THEIR JURISDICTIONS. IN PARTICULAR, THE DISTRIBUTION OF THE ANNOUNCEMENT MAY BE RESTRICTED BY LAW IN CERTAIN JURISDICTIONS.

 

Note that any references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". Any references to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

 

28 August 2015

FOR IMMEDIATE RELEASE

 

Apax Global Alpha Limited

Notice of Transactions of Persons Discharging Managerial Responsibilities ("PDMRs")

 

This notification is made in accordance with DTR 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

 

Grant of option

 

The Company has been informed that on 28 August 2015 Apax Guernsey (HOLDCO) PCC Ltd granted an option over 2,750,000 shares in the Company to Ralf Gruss, a PDMR. The exercise price of the option is EUR 1.96 per Share.

 

A tranche of the option vests on grant with the balance vesting monthly. The option will be fully vested on 31 October 2019. It will lapse if not exercised within five years of 31 October 2019.

 

The Company is not a party to the deed granting this option.

 

Investor Relations

Lorraine Rees

 

Telephone:

+44 (0)20 7872 6300

Email:

investor.relations@apaxglobalalpha.com

 

Media enquiries (Apax Global Alpha Limited)

Alex Jones

 

Telephone:

+44 (0)20 7952 2000

Email:

aga@greenbrookpr.com

 

Media enquiries (Apax Partners LLP)

Alex Wessendorff

 

Telephone:

+44 (0)20 7872 6461

Email:

alex.wessendorff@apax.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDICGDBGUI
Date   Source Headline
19th Aug 20217:00 amRNS2021 Interim Dividend
19th Aug 20217:00 amRNS2021 Interim Report and Accounts
19th Aug 20217:00 amRNS2021 Interim Results Highlights
5th Aug 20217:00 amRNSApax Funds’ Valuations as at 30 June 2021
4th Aug 20217:00 amRNSApax Funds create social good software platform
22nd Jul 20217:00 amRNSInitial Public Offering of Paycor
14th Jul 20217:00 amRNSFunds advised by Apax announce investment in Tide
6th Jul 20217:00 amRNSIPO of Baltic Classifieds Group
24th Jun 20217:00 amRNSApax Funds announce investment in Revolution Prep
16th Jun 20217:00 amRNSApax Funds invest in CyberGrants
14th Jun 20217:00 amRNSFunds advised by Apax to acquire Infogain
27th May 20217:00 amRNSProposed commitment to Apax Digital Fund II
25th May 20217:00 amRNSFunds advised by Apax invest in Faculty
20th May 20217:00 amRNSResult of secondary placing in Apax Global Alpha
19th May 20214:35 pmRNSSecondary placing of shares in Apax Global Alpha
14th May 20217:00 amRNSInitial Public Offering of Global-e
14th May 20217:00 amRNSFunds advised by Apax to acquire Nulo
5th May 20217:00 amRNSQuarterly results for 31 March 2021
4th May 20215:40 pmRNSResult of AGM
28th Apr 20217:00 amRNSFunds advised by Apax Partners invest in Guesty
26th Mar 20213:05 pmRNSHolding(s) in Company
25th Mar 20217:00 amRNSFunds advised by Apax to acquire Rodenstock Group
19th Mar 20217:00 amRNSResult of secondary placing in Apax Global Alpha
18th Mar 20214:51 pmRNSSecondary placing of shares in Apax Global Alpha
17th Mar 20217:00 amRNSFunds advised by Apax to acquire Lutech
10th Mar 20212:03 pmRNSInitiation research from QuotedData
9th Mar 20215:40 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSInitial Public Offering of InnovAge
2nd Mar 20219:54 amRNS2020 Annual Dividend Declaration
2nd Mar 20217:00 amRNSKey Information Document
2nd Mar 20217:00 amRNSNotice of AGM
2nd Mar 20217:00 amRNS2020 Annual Dividend
2nd Mar 20217:00 amRNS2020 Annual Report and Accounts
2nd Mar 20217:00 amRNS2020 Final Results
15th Feb 202110:45 amRNSDirector Declaration
12th Feb 20217:00 amRNSFunds advised by Apax to acquire Herjavec Group
5th Feb 20217:00 amRNSApax Funds’ Valuations as at 31 December 2020
28th Jan 20217:00 amRNSApax Digital Fund sells stake in Signavio
26th Jan 20217:00 amRNSFunds Advised by Apax acquire PIB Group
19th Jan 202110:30 amRNSAmendment to Revolving Credit Facility
5th Jan 20217:00 amRNSThe Apax Funds sell minority stake in Paycor
29th Dec 20207:00 amRNSFunds Advised by Apax Partners sell Boats Group
29th Dec 20207:00 amRNSFunds Advised by Apax invest in Azentio Software
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
27th Nov 20201:43 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSFunds Advised by Apax Partners sell ECI
4th Nov 20207:00 amRNSQuarterly results for 30 September 2020
28th Oct 20207:00 amRNSGenius Sports Group SPAC
22nd Sep 20207:00 amRNSFunds advised by Apax Partners sell Neuraxpharm

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.